Previous Article | Next Article 
Journal of Virology, July 2005, p. 8861-8869, Vol. 79, No. 14
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.14.8861-8869.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells
Anna Smed-Sörensen,1*
Karin Loré,2
Jayanand Vasudevan,2
Mark K. Louder,3
Jan Andersson,1
John R. Mascola,3
Anna-Lena Spetz,1 and
Richard A. Koup2
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden,1
Immunology Laboratory,2
BSL-3 Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland3
Received 30 November 2004/
Accepted 26 March 2005
Human immunodeficiency virus type 1 (HIV-1) infection of dendritic cells (DCs) plays an important role in HIV-1 transmission and pathogenesis. Here, we studied the susceptibility of ex vivo-isolated CD11c+ myeloid DCs (MDCs) and CD123+ plasmacytoid DCs (PDCs) to HIV-1 infection and the function of these cells early after infection. Both DC subsets were susceptible to CCR5- and CXCR4-using HIV-1 isolates (BaL and IIIB, respectively). However, MDCs were more susceptible to HIV-1BaL infection than donor-matched PDCs. In addition, HIV-1BaL infected MDCs more efficiently than HIV-1IIIB, whereas PDCs were equally susceptible to both isolates. While exposure to HIV-1 alone resulted in only weak maturation of DCs, Toll-like receptor 7/8 ligation induced full maturation in both infected and uninfected DCs. Maturation did not increase HIV-1 replication in infected DCs, and infected DCs retained their ability to produce tumor necrosis factor alpha after stimulation. Both HIV-1 isolates induced alpha interferon production exclusively in PDCs, irrespective of productive infection. In conclusion, PDCs and MDCs were susceptible to HIV-1 infection, but neither displayed functional defects as a consequence of infection. The difference in susceptibility of PDCs and MDCs to HIV-1 may have implications for HIV-1 transmission and DC-mediated transfer of HIV-1 to T cells.
* Corresponding author. Mailing address: Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, F59 Huddinge University Hospital, S-141 86 Stockholm, Sweden. Phone: 46 8 585 896 88. Fax: 46 8 746 76 37. E-mail:
Anna.Smed.Sorensen{at}medhs.ki.se.
Journal of Virology, July 2005, p. 8861-8869, Vol. 79, No. 14
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.14.8861-8869.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Harman, A. N., Kraus, M., Bye, C. R., Byth, K., Turville, S. G., Tang, O., Mercier, S. K., Nasr, N., Stern, J. L., Slobedman, B., Driessen, C., Cunningham, A. L.
(2009). HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood
114: 85-94
[Abstract]
[Full Text]
-
Adams, W. C., Bond, E., Havenga, M. J. E., Holterman, L., Goudsmit, J., Karlsson Hedestam, G. B., Koup, R. A., Lore, K.
(2009). Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. J. Gen. Virol.
90: 1600-1610
[Abstract]
[Full Text]
-
Donaghy, H., Bosnjak, L., Harman, A. N., Marsden, V., Tyring, S. K., Meng, T.-C., Cunningham, A. L.
(2009). Role for Plasmacytoid Dendritic Cells in the Immune Control of Recurrent Human Herpes Simplex Virus Infection. J. Virol.
83: 1952-1961
[Abstract]
[Full Text]
-
Liu, B., Woltman, A. M., Janssen, H. L. A., Boonstra, A.
(2009). Modulation of dendritic cell function by persistent viruses. J. Leukoc. Biol.
85: 205-214
[Abstract]
[Full Text]
-
Catalfamo, M., Di Mascio, M., Hu, Z., Srinivasula, S., Thaker, V., Adelsberger, J., Rupert, A., Baseler, M., Tagaya, Y., Roby, G., Rehm, C., Follmann, D., Lane, H. C.
(2008). HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc. Natl. Acad. Sci. USA
105: 19851-19856
[Abstract]
[Full Text]
-
van Montfort, T., Thomas, A. A. M., Pollakis, G., Paxton, W. A.
(2008). Dendritic Cells Preferentially Transfer CXCR4-Using Human Immunodeficiency Virus Type 1 Variants to CD4+ T Lymphocytes in trans. J. Virol.
82: 7886-7896
[Abstract]
[Full Text]
-
Wang, Q., Pang, S.
(2008). An intercellular adhesion molecule-3 (ICAM-3) -grabbing nonintegrin (DC-SIGN) efficiently blocks HIV viral budding. FASEB J.
22: 1055-1064
[Abstract]
[Full Text]
-
Duvall, M. G., Lore, K., Blaak, H., Ambrozak, D. A., Adams, W. C., Santos, K., Geldmacher, C., Mascola, J. R., McMichael, A. J., Jaye, A., Whittle, H. C., Rowland-Jones, S. L., Koup, R. A.
(2007). Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection. J. Virol.
81: 13486-13498
[Abstract]
[Full Text]
-
Dong, C., Janas, A. M., Wang, J.-H., Olson, W. J., Wu, L.
(2007). Characterization of Human Immunodeficiency Virus Type 1 Replication in Immature and Mature Dendritic Cells Reveals Dissociable cis- and trans-Infection. J. Virol.
81: 11352-11362
[Abstract]
[Full Text]
-
Lore, K., Adams, W. C., Havenga, M., Precopio, M. L., Holterman, L., Goudsmit, J., Koup, R. A.
(2007). Myeloid and Plasmacytoid Dendritic Cells Are Susceptible to Recombinant Adenovirus Vectors and Stimulate Polyfunctional Memory T Cell Responses. J. Immunol.
179: 1721-1729
[Abstract]
[Full Text]
-
Gilbert, C., Cantin, R., Barat, C., Tremblay, M. J.
(2007). Human Immunodeficiency Virus Type 1 Replication in Dendritic Cell-T-Cell Cocultures Is Increased upon Incorporation of Host LFA-1 due to Higher Levels of Virus Production in Immature Dendritic Cells. J. Virol.
81: 7672-7682
[Abstract]
[Full Text]
-
Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., Wahl, S. M.
(2007). Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood
110: 393-400
[Abstract]
[Full Text]
-
Brown, B. D., Sitia, G., Annoni, A., Hauben, E., Sergi, L. S., Zingale, A., Roncarolo, M. G., Guidotti, L. G., Naldini, L.
(2007). In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood
109: 2797-2805
[Abstract]
[Full Text]
-
Wang, J.-H., Janas, A. M., Olson, W. J., KewalRamani, V. N., Wu, L.
(2007). CD4 Coexpression Regulates DC-SIGN-Mediated Transmission of Human Immunodeficiency Virus Type 1. J. Virol.
81: 2497-2507
[Abstract]
[Full Text]
-
Cameron, P. U., Handley, A. J., Baylis, D. C., Solomon, A. E., Bernard, N., Purcell, D. F. J., Lewin, S. R.
(2007). Preferential Infection of Dendritic Cells during Human Immunodeficiency Virus Type 1 Infection of Blood Leukocytes. J. Virol.
81: 2297-2306
[Abstract]
[Full Text]
-
Harman, A. N., Wilkinson, J., Bye, C. R., Bosnjak, L., Stern, J. L., Nicholle, M., Lai, J., Cunningham, A. L.
(2006). HIV Induces Maturation of Monocyte-Derived Dendritic Cells and Langerhans Cells. J. Immunol.
177: 7103-7113
[Abstract]
[Full Text]
-
Chougnet, C., Gessani, S.
(2006). Role of gp120 in dendritic cell dysfunction in HIV infection. J. Leukoc. Biol.
80: 994-1000
[Abstract]
[Full Text]
-
Hosmalin, A., Lebon, P.
(2006). Type I interferon production in HIV-infected patients. J. Leukoc. Biol.
80: 984-993
[Abstract]
[Full Text]
-
Donaghy, H., Wilkinson, J., Cunningham, A. L.
(2006). HIV interactions with dendritic cells: has our focus been too narrow?. J. Leukoc. Biol.
80: 1001-1012
[Abstract]
[Full Text]
-
Groot, F., van Capel, T. M. M., Kapsenberg, M. L., Berkhout, B., de Jong, E. C.
(2006). Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition. Blood
108: 1957-1964
[Abstract]
[Full Text]
-
Zhang, Z., Fu, J., Zhao, Q., He, Y., Jin, L., Zhang, H., Yao, J., Zhang, L., Wang, F.-S.
(2006). Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy. J. Immunol.
176: 5644-5651
[Abstract]
[Full Text]
-
Teleshova, N., Kenney, J., Robbiani, M.
(2006). Dendritic Cells and HIV Infection: Activating Dendritic Cells to Boost Immunity. ADR
19: 36-41
[Abstract]
[Full Text]